Lb Pharmaceuticals (LBRX) Other Non-Current Assets (2024 - 2026)

Lb Pharmaceuticals' Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $776000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets changed N/A year-over-year to $776000.0; the TTM figure through Mar 2026 stood at $776000.0 (changed N/A YoY), while the FY2025 annual figure was $770000.0, up 54.62% from the prior year.
• Other Non-Current Assets was $776000.0 for Q1 2026 at Lb Pharmaceuticals, up from $770000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $776000.0 in Q1 2026 to a low of $498000.0 in Q4 2024.
• Historically, Other Non-Current Assets has averaged $639000.0 across 3 years, with a median of $641000.0 in 2025.
• Biggest YoY gain for Other Non-Current Assets was 54.62% in 2025; the steepest drop was 54.62% in 2025.
• A 3-year view of Other Non-Current Assets shows it stood at $498000.0 in 2024, then jumped by 54.62% to $770000.0 in 2025, then rose by 0.78% to $776000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $776000.0 (Q1 2026), $770000.0 (Q4 2025), and $512000.0 (Q3 2025), per Business Quant data.